Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). (Q34954705)

5 August 2017

1 reference

title

Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). (English)

1 reference

5 August 2017

main subject

glycogen storage disease

1 reference

Jan Peter Rake

1

1 reference

5 August 2017

Gepke Visser

2

1 reference

5 August 2017

Philippe Labrune

3

1 reference

5 August 2017

James V Leonard

4

1 reference

5 August 2017

Kurt Ullrich

5

1 reference

5 August 2017

G Peter A Smit

6

1 reference

5 August 2017

European Study on Glycogen Storage Disease Type I (ESGSD I)

7

1 reference

5 August 2017

publication date

24 August 2002

1 reference

European Journal of Pediatrics

5 August 2017

published in

1 reference

5 August 2017

volume

161 Suppl 1

1 reference

5 August 2017

page(s)

S112-9

1 reference

Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Glycogen storage disease I and hepatocellular tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Type I glycogen storage disease: nine years of management with cornstarch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Glycogen storage disease: recommendations for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Effects of cornstarch treatment in very young children with type I glycogen storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Uncooked cornstarch--efficacy in type I glycogenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Liver transplantation for glycogen storage disease types I, III, and IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Renal function and kidney size in glycogen storage disease type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

Decreased urinary citrate excretion in type 1a glycogen storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02680007

21 January 2018

Identifiers

DOI

10.1007/BF02680007

1 reference

Dimensions Publication ID

5 August 2017

1014402446

0 references

1 reference